By: ifood.tv

Eye Movements and Reading Disabilities

May 22, 2013 No Comments

The mechanism of the eye movement anomalies seen in dyslexic patients is not well defined. Some optometrists use observational eye movement tests as screening devices for dyslexia and advocate eye movement therapy as a treatment option for dyslexia. The reliability of the clinical eye movement tests and the efficacy of the eye movement therapies have [...]

Read more

Effect of RIC on Clinical Outcomes in STEMI Patients Undergoing pPCI

May 20, 2013 No Comments

The aim of the the study is to investigate whether Remote Ischaemic Conditioning (RIC) can improve clinical outcomes (cardiovascular death and hospitalisation for heart failure) at one year in patients presenting with ST-elevation Myocardial Infarction and undergoing primary percutaneous coronary intervention. This will be done in a multinational investigator-driven, multi-centre, randomised, controlled, single-blind, parallel assignment, [...]

Read more

Efficacy and Safety Study of Etodolac and Propranolol in Patients With Clinically Progressive Prostate Cancer

May 20, 2013 No Comments

The purpose of this study is to evaluate the clinical benefit of the co-administration of propranolol and etodolac (VT-122 therapy) in patients with clinically progressive prostate cancer. Clinical Trial Conditions: Prostatic Neoplasms Treatments in this Clinical Trial : VT-122, Placebo Clinical Trial Phase: Phase 2 Eligible Clinical Trial Participant Age : Between 18 years to [...]

Read more

Combination Effects of High-dose Statin and Trimetazidine on Patients With Aspirin Mono Antiplatelet Therapy 12-months After Coronary Artery Bypass Surgery

May 20, 2013 No Comments

Trimetazidine is a metabolic agent without any negative inotropic or vasodilatory properties. In addition, previous reports showed that trimetazidine was effective in reducing intracoronary platelet aggregation and preventing platelet thrombogenesis. Therefore, for the evaluation of these combination effects of statin and trimetazidine on patients with aspirin monotherapy who had previously received CABG and were free [...]

Read more

Use of TpCO2 (Transcutaneous CO2 Measurement) as PaCO2 Predictor During NIV in Case of Acute Hypercapnic Respiratory Failure

May 20, 2013 No Comments

In patients suffering from hypercapnic respiratory failure and treated by non invasive ventilation (NIV), the interest of using transcutaneous CO2 measurement to evaluate PaCO2 and PaCO2 variation over time is unknown and will be evaluated in this study. Measurements will be done during one-hour NIV treatments. Clinical Trial Conditions: Hypercapnic Respiratory Failure Eligible Clinical Trial [...]

Read more

Evaluation of an Aerobic Exercise Program in Migraine Management

May 20, 2013 No Comments

This trial assesses the impact of a supervised aerobic exercise program by a kinesiologist in patients with migraine. Patients can be assigned to one of two groups 1)The exercise group or 2)non-exercise group. This is a important area to study because there is currently limited information regarding exercise and its impact on migraine frequency and [...]

Read more

Overnight Closed Loop Study in U.S.

May 20, 2013 No Comments

This is a multicenter feasibility study. Up to 85 subjects will be enrolled in the study. The goal of the study is to demonstrate that the Overnight Closed Loop (OCL) System is safe to be used in an even larger study outside of hospital. Clinical Trial Conditions: Type 1 Diabetes Treatments in this Clinical Trial [...]

Read more

Efficacy of a Clinic-based Multi- Disciplinary Pediatric Weight Management Program

May 20, 2013 No Comments

Childhood obesity has more than tripled in the past 30 years. From 1980 to 2008, the prevalence of obesity among adolescents aged 12 to 18 years, increased from 5.0% to 18.1%.1 Although several pediatric weight management programs are available, access to these programs may not always be possible. The proposed study will be an ongoing [...]

Read more

Integrated PTSD and Smoking Treatment

May 20, 2013 No Comments

Research shows that people with PTSD are more likely to smoke than people without PTSD. It also shows that people with PTSD have more difficulty at attempts to quit smoking. This study is part of a program aimed at finding out how best to help smokers quit who also have PTSD. One option is to [...]

Read more

Concurrent Chemoradiation + 5-FU + Mitomycin-C in Anal Carcinoma

May 20, 2013 No Comments

This research study is a Pilot Study. Pilot studies are conducted to see if it is practical to do this type of research ona larger scale in the future. The pilot part of the study is to assess the possibility of using pencil beam proton radiation to treat your type of cancer. Proton radiation is [...]

Read more

Proof-Of-Concept Investigation With a Neurosteroid Analog (Ganaxolone) as a Smoking Cessation Candidate

May 20, 2013 No Comments

The purpose of this research study is to evaluate whether the investigational drug ganaxolone can help smokers quit smoking. Ganaxolone is a drug that has been investigated (in other research studies) for the treatment of seizures and migraines. This drug is considered investigational in the US. Clinical Trial Conditions: Smoking Cessation Treatments in this Clinical [...]

Read more

Intensive Models of HCV Care for Injection Drug Users

May 20, 2013 No Comments

Injection drug users (IDUs) constitute 60% of the approximately 5 million people in the U.S. infected with hepatitis C virus (HCV). HCV treatment leading to sustained viral response (SVR) is associated with increased survival. However, IDUs have had poor access to HCV care and their success in HCV treatment has been limited. With direct-acting antiviral [...]

Read more

Prognosis Value of Pro-adrenomedullin in Acute Exacerbations of COPD in ER

May 20, 2013 No Comments

The purpose of this study is to determine whether pro-adrenomedullin (Mr proADM)in addition to clinical evaluation is effective to predict outcome of acute exacerbations of COPD patients visiting the emergency room(ER). Clinical Trial Conditions: COPD Patients Admitted in ER for Acute Exacerbation Treatments in this Clinical Trial : AECOPD Mr proADM Eligible Clinical Trial Participant [...]

Read more

Vitamin D Status in Lower Extremity Joint Replacement Surgery Patients

May 20, 2013 No Comments

In the United States, ~1 million elective hip or knee replacement surgeries are performed annually. With estimated surgical site infection (SSI) rates as high as 2.5%, this represents ~25,000 patients at risk of potentially avoidable morbidity following lower extremity joint replacement surgery. Although SSIs only account for 20% of all HAIs, they are a major [...]

Read more

Dose-finding Study of APD403 to Prevent Nausea and Vomiting After Chemotherapy

May 20, 2013 No Comments

Comparison of efficacy of APD403 at preventing delayed sickness in patients who have received cancer chemotherapy Clinical Trial Conditions: CINV Treatments in this Clinical Trial : Ondansetron, dexamethasone, fosaprepitant, Placebo Clinical Trial Phase: Phase 2 Eligible Clinical Trial Participant Age : Between 18 years to 100 years Can Healthy Volunteers Participate: No Clinical Trial Lead [...]

Read more

Green Tea Confections For Managing Postprandial Hyperglycemia-Induced Vascular Endothelial Dysfunction

May 20, 2013 No Comments

The objective of this study is to formulate and validate a green tea confection (i.e. "gummy" candy) as a strategy to attenuate postprandial hyperglycemia-induced impairments in vascular function. The central hypothesis is that a green tea confection will protect against vascular endothelial dysfunction by suppressing postprandial hyperglycemia. The central hypothesis of this application will be [...]

Read more

Bioequivalence of Orfadin 20 mg Compared to Orfadin 10 mg Capsules.

May 20, 2013 No Comments

The purpose of this study is to evaluate the bioequivalence between Orfadin 20 mg and 10 mg capsules in healthy volunteers. Clinical Trial Conditions: Healthy Treatments in this Clinical Trial : Nitisinone 1 x 20 mg capsules, Nitisinone 2 x 10 mg capsules Clinical Trial Phase: Phase 1 Eligible Clinical Trial Participant Age : Between [...]

Read more

Study of the Efficacy and Safety of MK-0476 in Japanese Pediatric Participants With Seasonal Allergic Rhinitis (MK-0476-519 AM1)

May 20, 2013 No Comments

This study will evaluate the efficacy and safety of MK-0476 in the treatment of Japanese pediatric participants with seasonal allergic rhinitis (SAR). Clinical Trial Conditions: Seasonal Allergic Rhinitis Treatments in this Clinical Trial : MK-0476, Placebo Clinical Trial Phase: Phase 3 Eligible Clinical Trial Participant Age : Between 10 years to 15 years Can Healthy [...]

Read more

Predicting Treatment Response to Stimulants in Adult ADHD Using Functional Magnetic Resonance Imaging

May 20, 2013 No Comments

The primary aim of this study is to assess the predictability of treatment response to stimulants in adults with ADHD using functional magnetic resonance This study will be a six-week, open-label study including adults ranging from age 18-55 with ADHD. Clinical Trial Conditions: ADHD Treatments in this Clinical Trial : OROS-MPH Clinical Trial Phase: Phase [...]

Read more

Depression in Adolescents. A Cerebral Structural Diffusion and Functional Magnetic Resonance Imaging Study

May 20, 2013 No Comments

Adolescence is a critical period for the development of depressive disorders. As adolescence also is a critical period for brain maturation, it may be hypothesized that maturation changes in emotional circuits could underlie vulnerability for depression. The aims of the study are (1) to identify the changes in brain morphometry, white matter microstructure, and functioning, [...]

Read more

Therapy for Children With Advanced Stage Neuroblastoma

May 20, 2013 No Comments

Neuroblastoma is the most common extracranial solid tumor in childhood, with nearly 50% of patients presenting with widespread metastatic disease. The current treatment for this group of high-risk patients includes intensive multi-agent chemotherapy (induction) followed by myeloablative therapy with stem-cell rescue (consolidation) and then treatment of minimal residual disease (MRD) with isotretinoin. Recently a new [...]

Read more

Treatment of Extraesophageal Reflux With the Reza Band UES Assist Device

May 20, 2013 No Comments

The purpose of the study is to determine the safety and effectiveness of non-invasive Reza Band UES Assist Device for the treatment of esophagopharyngeal reflux with extra-esophageal symptoms (chronic cough, choking, aspiration, chronic post nasal drip, globus, sore throat, throat clearing). Clinical Trial Conditions: Extraesophageal Reflux Disease Treatments in this Clinical Trial : Reza Band [...]

Read more

A STUDY TO EVALUATE AIR LEAK DETECTION ABOVE THE ENDOTRACHEAL CUFF IN INTUBATED PATIENTS USING THE ANAPNOGUARD 100 SYSTEM

May 20, 2013 No Comments

This trial is designed to assess the effectiveness of the AnapnoGaurd 100 system relative to standard of care (SOC) Control, in the course of mechanical ventilation and intubation. The main effectiveness aspect of this trial is the AnapnoGaurd 100's ability to reduce leaks between the endotracheal tube and the trachea walls as a result of [...]

Read more

G-CSF Moblized Peripheral Harvest for Poor Engraftment After Stem Cell Transplantation

May 20, 2013 No Comments

Poor graft function (PGF) is a common complication after allogeneic stem cell transplantation, which was associated with high mortality. The pathogenesis fo PGF was poorly understood. Infusion of donor peripheral cell harvest was effective for some patients with PGF in our preliminary study. This present study aimed to explore the efficacy of peripheral cell harvest [...]

Read more

Insulin Resistance in HCV Infection

May 20, 2013 No Comments

The study hypothesis is that the means by which HCV induces glucose intolerance is through impairment of B-cell function and compensatory hyperinsulinemia in predisposed Latinos with insulin resistance and that HCV eradication improves these abnormalities. Clinical Trial Conditions: Insulin Secretion, Insulin Resistance Eligible Clinical Trial Participant Age : Between 18 years to 60 years Can [...]

Read more
By: ifood.tv